Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Flexion Therapeutics Inc | Chief Commercial Officer | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
Flexion Therapeutics Inc | Chief Commercial Officer | Performance Restricted Stock Unit Award | 0 | Nov 19, 2021 | Direct | ||
Flexion Therapeutics Inc | Chief Commercial Officer | Stock Option (right to buy) | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 3 | -$884K | 4 | Nov 19, 2021 | Chief Commercial Officer |